|
LOC729176 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.74991140969405E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4941003989577E-10 |
| Normal-vs-Stage2 |
1.16679999995206E-06 |
| Normal-vs-Stage3 |
6.97960023110511E-10 |
| Normal-vs-Stage4 |
5.55550050407305E-10 |
| Stage1-vs-Stage2 |
6.014200E-01 |
| Stage1-vs-Stage3 |
1.013950E-01 |
| Stage1-vs-Stage4 |
2.476000E-02 |
| Stage2-vs-Stage3 |
5.469400E-01 |
| Stage2-vs-Stage4 |
1.883600E-01 |
| Stage3-vs-Stage4 |
4.136000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45800038708899E-11 |
| Normal-vs-AfricanAmerican |
2.608100E-04 |
| Normal-vs-Asian |
5.88519999999981E-05 |
| Caucasian-vs-AfricanAmerican |
8.519800E-01 |
| Caucasian-vs-Asian |
3.873000E-01 |
| AfricanAmerican-vs-Asian |
7.034800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.52069492951068E-11 |
| Normal-vs-Female |
2.68020050597784E-11 |
| Male-vs-Female |
4.075000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.24700003048639E-09 |
| Normal-vs-Age(41-60Yrs) |
7.01539937253415E-11 |
| Normal-vs-Age(61-80Yrs) |
3.59560003992954E-09 |
| Normal-vs-Age(81-100Yrs) |
2.955400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.154600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.383600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.949800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.950400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.019400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.437000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.981400E-01 |
| Classical-VS-Follicular |
6.804000E-01 |
| Classical-VS-Other |
2.938400E-01 |
| Classical-VS-Normal |
3.10169999684362E-08 |
| Tall-VS-Follicular |
8.940200E-01 |
| Tall-VS-Other |
4.850200E-01 |
| Tall-VS-Normal |
1.77034999999659E-05 |
| Follicular-VS-Other |
5.236600E-01 |
| Follicular-VS-Normal |
6.54930000010268E-07 |
| Other-VS-Normal |
2.081300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.8810955277645E-11 |
| Normal-vs-N1 |
1.03240005433491E-09 |
| N0-vs-N1 |
2.558800E-01 |
|
|
